Quotient Clinical and Bend Research Announce Collaboration To Accelerate Advancement of New Medicines
10 November 2010 | By The Scott Partnership
Speeding the advance of compounds to clinical trials and expanding options for drug delivery...
List view / Grid view
News
Thermo Fisher Scientific Launches Mass Frontier 7.0
Thermo Fisher Scientific Inc., the world leader in serving science, today announced Mass Frontier 7.0, the newest release of its small molecule structural elucidation software. The software simplifies the management, evaluation and interpretation of mass spectral data and can be used for metabolism, metabolomics, forensics, natural products, impurities and degradants…
Algeta appoints Lars Abrahmsén as Senior Vice President, Protein Therapeutics
10 November 2010 | By Citigate Dewe Rogerson
Algeta ASA announces that Dr. Lars Abrahmsén has been appointed as Senior Vice President, Protein Therapeutics...
Next Generation Drug Development Summit: Imaging Biomarkers
9 November 2010 | By NG Online News
Senior executives from Eli Lilly, AstraZeneca, Johnson and Johnson & Pfizer to discuss the ROI for "non-surrogate" biomarkers, dose selection biomarkers and biomarkers of efficacy.
Unilabs – York Bioanalytical Solutions, YBS, appoints David J Browne to Business Development Manager
9 November 2010 | By Unilabs YBS
Unilabs YBS announce that David J Browne has joined as Business Development Manager...
Genentech’s ECP-1 Bacterial Manufacturing Facility Named 2010 Facility of the Year Awards Overall Winner
8 November 2010 | By ISPE
ISPE, announced that Genentech’s ECP-1 Bacterial Manufacturing Facility is the overall winner...
Wragge & Co enhances IP practice with new partner hire
8 November 2010 | By Wragge & Co LLP
Wragge & Co has boosted its IP capability with the appointment of a new partner...
KOMBIGLYZE™ XR tablets approved in the US for the treatment of type 2 diabetes mellitus in adults
AstraZeneca and Bristol-Myers Squibb Company today announced that the US Food and Drug Administration (FDA) approved KOMBIGLYZE™ XR for the treatment of type 2 diabetes in adults. KOMBIGLYZE XR is the first and only once-a-day metformin extended-release (XR) plus dipeptidyl peptidase-4 (DPP-4) inhibitor combination tablet offering strong glycaemic control across…
Wyatt Technology MALS Detectors
4 November 2010 | By The Scott Partnership
Enable Pharmaceutical Manufacturers to Perform Easy and Reliable Transmembrane Protein Characterization...
Sigma® Life Science collaborates with The Jackson Laboratory for distribution of genetically engineered mice
4 November 2010 | By kdm communications limited
JAX to distribute mouse models created using proprietary ZFN technology...
Quotient Bioresearch Celebrates Official Opening of New State-of-the-Art Radiochemistry Facility
3 November 2010 | By The Scott Partnership
Quotient Bioresearch, has officially opened its new, state-of-the-art radiochemistry facility in Cardiff...
Specialist Business Unit of the University of Nottingham Spins-Out to Form New R&D Oncology Company
3 November 2010 | By The Scott Partnership
PRECOS, announces its official launch following its spin-out from the University of Nottingham...
Prism Ideas Announces Collaboration with University of Liverpool to Prepare Students for Careers in Medical Communications
3 November 2010 | By The Scott Partnership
Prism Ideas, announced that the company will be collaborating with the University of Liverpool...
Molecular Profiles unveils new capabilities at AAPS 2010
2 November 2010 | By The Scott Partnership
Molecular Profiles announces it is to demonstrate its expansion of capabilities at the upcoming AAPS / FIP Pharmaceutical Sciences World Congress 2010, booth # 712...
Medivir appoints Vice President, Research & Development Projects
1 November 2010 | By M:Communications
Medivir AB, is pleased to announce the appointment of Charlotte Edenius to the new position of Vice President, Research & Development Projects, effective 1 November...
